摘要
目的:本研究对福建省医保药品单列门诊统筹支付开展调研,为推进政策的贯彻落实提供支持。方法:收集2020年7月-2021年8月福建省医药流通企业的药品数据,比较“医保药品单列门诊统筹支付”33个品种在政策实施前后的使用情况。结果:政策实施后各药品的销售金额均有所增长,受益患者数增加,药品单列门诊统筹支付节约了医疗费用。但不同统筹区、不同疾病领域的药品销售金额增长情况差别较大。结论:持续推进单列门诊统筹支付政策,建立单列门诊统筹支付政策的动态调整机制,多方联动以进一步推动相关政策的落地。
Objective:This study conducted an investigation on separate fund payment for drugs used by outpatient(SFPDO)in Fujian Province to further promote implementation of the policy.Methods:The data of SFPDO drugs were acquired from pharmaceutical distribution enterprises in Fujian Province from July 2020 to August 2021,and the use of 33 drugs before and after implementation of the policy was compared.Results:After the implementation of the SFPDO policy,the sales of each drug increased,indicating that the number of beneficiary patients increased.The medical expenses are saved by SFPDO.However,the growth of drug sales in different regions and dif ferent disease areas is quite dif ferent.Conclusion:SFPDO policy should be promoted and a dynamic adjustment mechanism for SFPDO policy should be established.Departments concerned should cooperate with each other to further promote the implementation of policy.
出处
《中国医疗保险》
2022年第7期88-92,共5页
China Health Insurance
关键词
门诊待遇
单列门诊统筹
统筹支付
outpatient benefit
separate fund payment for drugs used by outpatient(SFPDO)
overall payment